Proffitt & Goodson’s Amgen AMGN Stock Holding History

Proffitt & Goodson’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-80	Closed	-$25.8K	–	259
2024 Q3	$25.8K	Hold	80	–	–	﹤0.01%	193
2024 Q2	$25K	Hold	80	–	–	﹤0.01%	189
2024 Q1	$22.7K	Buy	+80	New	+$23.4K	﹤0.01%	180

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Proffitt & Goodson's AMGN Position: Q4 2024 in Review

Proffitt & Goodson sold out of Amgen (AMGN) in Q4 2024, closing a stake of 80 shares — an estimated $25.8K sold.

Proffitt & Goodson first reported a position in AMGN in Q1 2024 and held it in 3 quarters. The position peaked at $25.8K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

Proffitt & Goodson reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
Proffitt & Goodson sold 80 Amgen shares in Q4 2024, an estimated $25.8K.
Proffitt & Goodson first reported a position in Amgen in Q1 2024 and held it in 3 quarters.
Proffitt & Goodson's Amgen position peaked at $25.8K in Q3 2024.
2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Proffitt & Goodson's 13F filing for Q4 2024, filed 5 Feb 2025.